Emtricitabine Recruiting Phase 4 Trials for PrEP Adherence Monitoring Prevention

IndicationsStatusPurposePhase
RecruitingPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT03058835IN-US-276-1340: Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women: A Demonstration Project